https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=29743996&retmode=xml&tool=Litmetric&email=readroberts32@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29743996</PMID><DateCompleted><Year>2018</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1947-6108</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Season>Jul-Sep</Season></PubDate></JournalIssue><Title>Methodist DeBakey cardiovascular journal</Title><ISOAbbreviation>Methodist Debakey Cardiovasc J</ISOAbbreviation></Journal><ArticleTitle>Emerging Transcatheter Options for Tricuspid Regurgitation.</ArticleTitle><Pagination><StartPage>120</StartPage><EndPage>125</EndPage><MedlinePgn>120-125</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.14797/mdcj-13-3-120</ELocationID><Abstract><AbstractText>Tricuspid regurgitation (TR) presents as either primary valve pathology or secondary to pulmonary or left-sided heart disease. Severe TR portends a worse prognosis independent of age, right ventricular size and function, severe left ventricular dysfunction, and increased pulmonary arterial pressures. Surgical treatment for TR has mostly been limited to patients undergoing mitral valve repair since those at high surgical risk are not candidates for traditional TR surgery. For these patients, minimally invasive techniques could be of great benefit, yet these techniques have been slow to develop because of the various anatomic and physiological aspects of the tricuspid valve apparatus. Several promising new techniques are currently undergoing clinical investigation, including caval valve implantation, percutaneous tricuspid annuloplasty techniques (Trialign, TriCinch, Cardioband), edge-to-edge repair with the MitraClip system, the FORMA device, and the GATE tricuspid Atrioventricular Valved Stent. Further evaluation of their safety and long-term efficacy is warranted prior to commercial approval and widespread adoption.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kalra</LastName><ForeName>Ankur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>HOUSTON METHODIST DEBAKEY HEART &amp; VASCULAR CENTER, HOUSTON METHODIST HOSPITAL, HOUSTON, TEXAS.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WEILL CORNELL MEDICAL COLLEGE, NEW YORK, NEW YORK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER, CASE WESTERN RESERVE UNIVERSITY, CLEVELAND, OHIO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uberoi</LastName><ForeName>Angad S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>HOUSTON METHODIST DEBAKEY HEART &amp; VASCULAR CENTER, HOUSTON METHODIST HOSPITAL, HOUSTON, TEXAS.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Latib</LastName><ForeName>Azeem</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>EMO-GVM CENTRO CUORE COLUMBUS AND SAN RAFFAELE SCIENTIFIC INSTITUTE, MILAN, ITALY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khera</LastName><ForeName>Sahil</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>MASSACHUSETTS GENERAL HOSPITAL, HARVARD MEDICAL SCHOOL, BOSTON, MASSACHUSETTS.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Little</LastName><ForeName>Stephen H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>HOUSTON METHODIST DEBAKEY HEART &amp; VASCULAR CENTER, HOUSTON METHODIST HOSPITAL, HOUSTON, TEXAS.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WEILL CORNELL MEDICAL COLLEGE, NEW YORK, NEW YORK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhatt</LastName><ForeName>Deepak L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>BRIGHAM AND WOMEN'S HEART &amp; VASCULAR CENTER, HARVARD MEDICAL SCHOOL, BOSTON, MASSACHUSETTS.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reardon</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>HOUSTON METHODIST DEBAKEY HEART &amp; VASCULAR CENTER, HOUSTON METHODIST HOSPITAL, HOUSTON, TEXAS.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WEILL CORNELL MEDICAL COLLEGE, NEW YORK, NEW YORK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kleiman</LastName><ForeName>Neal S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>HOUSTON METHODIST DEBAKEY HEART &amp; VASCULAR CENTER, HOUSTON METHODIST HOSPITAL, HOUSTON, TEXAS.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WEILL CORNELL MEDICAL COLLEGE, NEW YORK, NEW YORK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barker</LastName><ForeName>Colin M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>HOUSTON METHODIST DEBAKEY HEART &amp; VASCULAR CENTER, HOUSTON METHODIST HOSPITAL, HOUSTON, TEXAS.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WEILL CORNELL MEDICAL COLLEGE, NEW YORK, NEW YORK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Methodist Debakey Cardiovasc J</MedlineTA><NlmUniqueID>101508600</NlmUniqueID><ISSNLinking>1947-6108</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006328" MajorTopicYN="Y">Cardiac Catheterization</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058385" MajorTopicYN="Y">Cardiac Valve Annuloplasty</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006350" MajorTopicYN="N">Heart Valve Prosthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019918" MajorTopicYN="Y">Heart Valve Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011474" MajorTopicYN="N">Prosthesis Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020127" MajorTopicYN="N">Recovery of Function</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="N">Stents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014261" MajorTopicYN="N">Tricuspid Valve</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014262" MajorTopicYN="N">Tricuspid Valve Insufficiency</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardioband</Keyword><Keyword MajorTopicYN="N">MitraClip</Keyword><Keyword MajorTopicYN="N">Mitralign</Keyword><Keyword MajorTopicYN="N">TriCinch</Keyword><Keyword MajorTopicYN="N">percutaneous transcatheter tricuspid valve repair</Keyword><Keyword MajorTopicYN="N">tricuspid regurgitation</Keyword></KeywordList><CoiStatement>Conflict of Interest Disclosure: Dr. Deepak Bhatt is on the advisory boards of Cardax, Elsevier Practice Update Cardiology, Medscape Cardiology, and Regado Biosciences and serves on the board of directors for Boston VA Research Institute and the Society of Cardiovascular Patient Care. He has received honoraria from his roles at the American College of Cardiology, Belvoir Publications, Duke Clinical Research Institute, Harvard Clinical Research Institute, HMP Communications, Population Health Research Institute, Slack Publications, Society of Cardiovascular Patient Care, and WebMD. He also receives research funding from Amarin, Amgen, AstraZeneca, Bristol-Myers Squibb, Eisai, Ethicon, Forest Laboratories, Ischemix, Lilly, Medtronic, Pfizer, Roche, Sanofi Aventis, and The Medicines Company as well as royalties from Elsevier. Finally, he is a site coinvestigator for Biotronik, Boston Scientific, and St. Jude Medical and a trustee of the American College of Cardiology.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29743996</ArticleId><ArticleId IdType="pmc">PMC5935195</ArticleId><ArticleId IdType="doi">10.14797/mdcj-13-3-120</ArticleId><ArticleId IdType="sici">i1947-6094-13-3-120</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nath J, Foster E, Heidenreich PA.. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004. February 4; 43 3: 405&#x2013; 9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15013122</ArticleId></ArticleIdList></Reference><Reference><Citation>Chikwe J, Itagaki S, Anyanwu A, Adams DH.. Impact of Concomitant Tricuspid Annuloplasty on Tricuspid Regurgitation, Right Ventricular Function, and Pulmonary Artery Hypertension After Repair of Mitral Valve Prolapse. J Am Coll Cardiol. 2015. May 12; 65 18: 1931&#x2013; 8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25936265</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornick P, Harris PA, Taylor KM.. Tricuspid valve replacement subsequent to previous open heart surgery. J Heart Valve Dis. 1996. January; 5 1: 20&#x2013; 5.</Citation><ArticleIdList><ArticleId IdType="pubmed">8834720</ArticleId></ArticleIdList></Reference><Reference><Citation>Fawzy H, Fukamachi K, Mazer CD, . et al. Complete mapping of the tricuspid valve apparatus using three-dimensional sonomicrometry. J Thorac Cardiovasc Surg. 2011. April; 141 4: 1037&#x2013; 43.</Citation><ArticleIdList><ArticleId IdType="pubmed">20591444</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda S, Saracino G, Matsumura Y, . et al. Three-dimensional geometry of the tricuspid annulus in healthy subjects and in patients with functional tricuspid regurgitation: a real-time, 3-dimensional echocardiographic study. Circulation. 2006. July 4; 114 1 Suppl: 1492&#x2013; 8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16820625</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin RB, Luckie M, Khattar RS.. Tricuspid regurgitation: contemporary management of a neglected valvular lesion. Postgrad Med J. 2010. November; 86 1021: 648&#x2013; 55.</Citation><ArticleIdList><ArticleId IdType="pubmed">20956397</ArticleId></ArticleIdList></Reference><Reference><Citation>Rod&#xe9;s-Cabau J, Hahn RT, Latib A, . et al. Transcatheter therapies for treating tricuspid regurgitation. J Am Coll Cardiol. 2016. April 19; 67 15: 1829&#x2013; 45.</Citation><ArticleIdList><ArticleId IdType="pubmed">27081024</ArticleId></ArticleIdList></Reference><Reference><Citation>Laule M, Stangl V, Sanad W, Lembcke A, Baumann G, Stangl K.. Percutaneous transfemoral management of severe secondary tricuspid regurgitation with Edwards Sapien XT bioprosthesis: first-in-man experience. J Am Coll Cardiol. 2013. May 7; 61 18: 1929&#x2013; 31.</Citation><ArticleIdList><ArticleId IdType="pubmed">23500268</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauten A, Doenst T, Hamadanchi A, Franz M, Figulla HR.. Percutaneous bicaval valve implantation for transcatheter treatment of tricuspid regurgitation: clinical observations and 12-month follow-up. Circ Cardiovasc Interv. 2014. April; 7 2: 268&#x2013; 72.</Citation><ArticleIdList><ArticleId IdType="pubmed">24737337</ArticleId></ArticleIdList></Reference><Reference><Citation>
ClinicalTrials.gov [Internet].
Bethesda, MD:
U.S. National Institutes of Health;
c2017. 
Heterotopic Implantation of the Edwards-Sapien XT Transcatheter Valve in the Inferior VEna Cava for the Treatment of Severe Tricuspid Regurgitation (HOVER); 2017 Jan 10 [cited 2017 Mar 6]. Available from: https://clinicaltrials.gov/ct2/show/NCT02339974.
</Citation></Reference><Reference><Citation>Kay JH, Maselli-Campagna G, Tsuji KK.. Surgical treatment of tricuspid insufficiency. Ann Surg. 1965. July; 162: 53&#x2013; 8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1476807</ArticleId><ArticleId IdType="pubmed">14313519</ArticleId></ArticleIdList></Reference><Reference><Citation>Schofer J, Bijuklic K, Tiburtius C, Hansen L, Groothuis A, Hahn RT.. First-in-human transcatheter tricuspid valve repair in a patient with severely regurgitant tricuspid valve. J Am Coll Cardiol. 2015. March 31; 65 12: 1190&#x2013; 5.</Citation><ArticleIdList><ArticleId IdType="pubmed">25748096</ArticleId></ArticleIdList></Reference><Reference><Citation>
ClinicalTrials.gov [Internet].
Bethesda, MD:
U.S. National Institutes of Health;
c2017. 
Early Feasibility of the Mitralign&#xae; Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as Tri-Align&#x2122; (SCOUT); 2016 Aug 17 [cited 2017 Mar 6]. Available from: https://clinicaltrials.gov/ct2/show/NCT02574650.
</Citation></Reference><Reference><Citation>Yzeiraj E, Sievert H, Nickenig G, Latib A, Hahn R, Schofer J.. TCT-86 Early Experience with the Trialign System for Transcatheter Tricuspid Valve Repair: A Multicenter Experience. J Am Coll Cardiol. 2016. November 1; 68 18S: B35.</Citation></Reference><Reference><Citation>Latib A, Agricola E, Pozzoli A, . et al. Firstin-Man Implantation of a Tricuspid Annular Remodeling Device for Functional Tricuspid Regurgitation. JACC Cardiovasc Interv. 2015. November; 8 13: e211&#x2013; 4.</Citation><ArticleIdList><ArticleId IdType="pubmed">26585629</ArticleId></ArticleIdList></Reference><Reference><Citation>
ClinicalTrials.gov [Internet].
Bethesda, MD:
U.S. National Institutes of Health;
c2017. 
Percutaneous Treatment of Tricuspid Valve Regurgitation With the TriCinch&#x2122; System (PREVENT); 2016 Dec 13 [cited 2017 Mar 6]. Available from: https://clinicaltrials.gov/ct2/show/NCT02098200.
</Citation></Reference><Reference><Citation>Kuwata S, Taramasso M, Nietlispach F, Maisano F.. Transcatheter tricuspid valve repair toward a surgical standard: first-in-man report of direct annuloplasty with a cardioband device to treat severe functional tricuspid regurgitation. Eur Heart J. 2017. April 21; 38 16: 1261.</Citation><ArticleIdList><ArticleId IdType="pubmed">28073862</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammerstingl C, Schueler R, Malasa M, Werner N, Nickenig G.. Transcatheter treatment of severe tricuspid regurgitation with the MitraClip system. Eur Heart J. 2016. March 7; 37 10: 849&#x2013; 53.</Citation><ArticleIdList><ArticleId IdType="pubmed">26744457</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun D, Nabauer M, Orban M, . et al. Transcatheter treatment of severe tricuspid regurgitation using the edge-to-edge repair technique. EuroIntervention. 2017. February 3; 12 15: e1837&#x2013; e1844.</Citation><ArticleIdList><ArticleId IdType="pubmed">28089953</ArticleId></ArticleIdList></Reference><Reference><Citation>Schueler R, Malasa M, Hammerstingl C, Nickenig G.. Transcatheter interventions for tricuspid regurgitation: MitraClip. EuroIntervention. 2016. September 18; 12 Y: Y108&#x2013; 9.</Citation><ArticleIdList><ArticleId IdType="pubmed">27640019</ArticleId></ArticleIdList></Reference><Reference><Citation>Schofer J, Tiburtius C, Hammerstingl C, . et al. Transfemoral Tricuspid Valve Repair Using a Percutaneous Mitral Valve Repair System. J Am Coll Cardiol. 2016. February 23; 67 7: 889&#x2013; 90.</Citation><ArticleIdList><ArticleId IdType="pubmed">26892424</ArticleId></ArticleIdList></Reference><Reference><Citation>Wengenmayer T, Zehender M, Bothe W, Bode C, Grundmann S.. First transfemoral percutaneous edge-to-edge repair of the tricuspid valve using the MitraClip system. EuroIntervention. 2016. April 20; 11 13: 1541&#x2013; 4.</Citation><ArticleIdList><ArticleId IdType="pubmed">27107316</ArticleId></ArticleIdList></Reference><Reference><Citation>Campelo-Parada F, Perlman G, Philippon F, . et al. First-in-Man Experience of a Novel Transcatheter Repair System for Treating Severe Tricuspid Regurgitation. J Am Coll Cardiol. 2015. December 8; 66 22: 2475&#x2013; 83.</Citation><ArticleIdList><ArticleId IdType="pubmed">26653620</ArticleId></ArticleIdList></Reference><Reference><Citation>
Business Wire [Internet].
New York, NY:
Business Wire, Inc.;
c2016. 
NaviGate Cardiac Structures Inc. (&#x201c;NCSI&#x201d;) Reports World's First Transcatheter Tricuspid Valved Stent is Successfully Implanted; 2016 Dec 30 [cited 2017 Mar 6]. Available from: http://www.businesswire.com/news/home/20161230005252/en/NaviGate-Cardiac-Structures-%E2%80%9CNCSI%E2%80%9D-Reports-World%E2%80%99s-Transcatheter.
</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>